These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24931194)

  • 21. Cannabinoid receptors and their relationships with neuropsychiatric disorders.
    Gambi F; De Berardis D; Sepede G; Quartesan R; Calcagni E; Salerno RM; Conti CM; Ferro FM
    Int J Immunopathol Pharmacol; 2005; 18(1):15-9. PubMed ID: 15698507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Activity-Based Screening for Synthetic Cannabinoid Receptor Agonists in a Large Set of Serum Samples.
    Cannaert A; Vandeputte M; Hudson S; Wood DM; Dargan PI; Stove CP
    Clin Chem; 2019 Feb; 65(2):347-349. PubMed ID: 30504261
    [No Abstract]   [Full Text] [Related]  

  • 23. Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography.
    Evens N; Bormans GM
    Curr Top Med Chem; 2010; 10(15):1527-43. PubMed ID: 20583994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patents targeting cannabinoid receptor type 2 ligands: an interview with Uwe Grether.
    Grether U
    Pharm Pat Anal; 2021 Jul; 10(4):175-177. PubMed ID: 34365800
    [No Abstract]   [Full Text] [Related]  

  • 25. Signal peptide and denaturing temperature are critical factors for efficient mammalian expression and immunoblotting of cannabinoid receptors.
    Wang C; Wang Y; Wang M; Chen J; Yu N; Song S; Kaminski NE; Zhang W
    J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):299-302. PubMed ID: 22528237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research progress on the roles of cannabinoid receptors in cardiovascular diseases].
    Cao MY; Gao P; Zou YZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):405-409. PubMed ID: 33874696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocannabinoid signalling and the deteriorating brain.
    Di Marzo V; Stella N; Zimmer A
    Nat Rev Neurosci; 2015 Jan; 16(1):30-42. PubMed ID: 25524120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?
    Dhopeshwarkar A; Mackie K
    Mol Pharmacol; 2014 Oct; 86(4):430-7. PubMed ID: 25106425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endocannabinoid system: directing eating behavior and macronutrient metabolism.
    Watkins BA; Kim J
    Front Psychol; 2014; 5():1506. PubMed ID: 25610411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid modulation of drug reward and the implications of marijuana legalization.
    Covey DP; Wenzel JM; Cheer JF
    Brain Res; 2015 Dec; 1628(Pt A):233-43. PubMed ID: 25463025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endocannabinoid system: a putative role in neurodegenerative diseases.
    Di Iorio G; Lupi M; Sarchione F; Matarazzo I; Santacroce R; Petruccelli F; Martinotti G; Di Giannantonio M
    Int J High Risk Behav Addict; 2013 Dec; 2(3):100-6. PubMed ID: 24971285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoid signaling at the periphery: 50 years after THC.
    Maccarrone M; Bab I; Bíró T; Cabral GA; Dey SK; Di Marzo V; Konje JC; Kunos G; Mechoulam R; Pacher P; Sharkey KA; Zimmer A
    Trends Pharmacol Sci; 2015 May; 36(5):277-96. PubMed ID: 25796370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macronutrient intakes in obese females.
    de Luis DA; Izaola O; Aller R; Lopez JJ; Torres B; Diaz G; Gomez E; Romero E
    J Hum Nutr Diet; 2016 Feb; 29(1):118-23. PubMed ID: 25664923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
    Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
    Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers.
    Tudge L; Williams C; Cowen PJ; McCabe C
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25542687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future.
    Panagis G; Mackey B; Vlachou S
    Front Psychiatry; 2014; 5():92. PubMed ID: 25132823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophrenia.
    Tan H; Ahmad T; Loureiro M; Zunder J; Laviolette SR
    Front Psychiatry; 2014; 5():73. PubMed ID: 25071606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
    Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
    Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development.
    Nguyen T; Thomas BF; Zhang Y
    Curr Top Med Chem; 2019; 19(16):1418-1435. PubMed ID: 31284863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.